Hot shot: the wider promise of weight-loss ja...

Control of the Strait of Hormuz has become the focus of the war in Iran. The options available point to an acute risk of a broadening regional conflict. China is making great strides in building humanoid robots—but so far they are more about entertainment than utility. And a look ...  Show more

As Israel continues to pound Iran and expands its offensive against Hizbullah in Lebanon, there are rumblings of disunity with America over the path and goal of the conflict. Why now is the time to buy rubbish stocks. And celebrating the life of grand-clown Philippe Gaulier. Gues ...  Show more

Snack-food companies have long shown their adaptability to changing diets. How could the rise of appetite-suppressing drugs and fears about ultra-processed foods change the food we consume? How hearing aids and other lifestyle choices can reduce your risk of dementia (11:00). And ...  Show more

Falling fertility makes a global decline in population inevitable. That will change the shape and make up of societies. But it may not make us poorer. Are large language models really woke? And reading is on the wane – and why that matters. Listen to what matters most, from globa ...  Show more

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs th ...